Website:
Facebook:
Leadership
President & Chief Executive Officer
Robert Mulroy
Senior Vice President & Chief Scientific Officer
Ulrik Nielsen PhD
Physic Team
Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is advancing a range of clinical and early-stage biologics that represent the next generation of patient-directed, targeted therapies. Their work is founded on a proprietary Network Biology research engine. Their lead product, MM-121, is currently in Phase 1 clinical trials for the treatment of oncology patients.
Merrimack in the News
-
Cambridge, MA Merrimack Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel...PR Web / April 13, 2011